Free Trial
→ Your book attached (From Profits Run) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ATT
Abattis Bioceuticals
C$0.00
C$0.05
▼
C$0.74
N/AN/A1.42 million shsN/A
Elon Musk's Next Move Cover
Elon Musk's Next Move

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ATT
Abattis Bioceuticals
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ATT
Abattis Bioceuticals
C$0.00
C$0.05
▼
C$0.74
N/AN/A1.42 million shsN/A
Elon Musk's Next Move Cover
Elon Musk's Next Move

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ATT
Abattis Bioceuticals
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ATT
Abattis Bioceuticals
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
ATT
Abattis Bioceuticals
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
ATT
Abattis Bioceuticals
N/A

Insider Ownership

CompanyInsider Ownership
ATT
Abattis Bioceuticals
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
ATT
Abattis Bioceuticals
N/AN/AN/ANot Optionable

Recent News About These Companies

Abattis Bioceuticals Stock Price History
May 27, 2025  |  investing.comhttps://www.investing.com/equities/abattis-bioceuticals-historical-data
Abattis Bioceuticals Corp. (ATTBF)
August 2, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/quote/ATTBF/news/
B.C. investment dealer that oversaw suspicious, 'unprofitable' trades fined $150K
February 14, 2024  |  richmond-news.comR
B.C. investment dealer who oversaw suspicious, 'unprofitable' trades fined $150K
February 13, 2024  |  vancouverisawesome.comV
Minoxidil Price of 85 Brands
August 1, 2023  |  medindia.netM
Abattis Bioceuticals Stock (OTC:ATTBF), Quotes and News Summary
February 23, 2023  |  benzinga.comhttps://www.benzinga.com/quote/ATTBF
Malaysian Bulk Carriers Bhd (MBCB)
July 26, 2022  |  investing.comhttps://www.investing.com/equities/malaysian-bulk-carriers-bhd
Metrc Enters Government Contract With The State Of South Dakota
March 24, 2022  |  benzinga.comhttps://www.benzinga.com/markets/cannabis/22/03/26256990/metrc-enters-government-contract-with-the-state-of-south-dakota
Cann American Cancels Over 3 Million Common Shares
March 5, 2022  |  benzinga.comhttps://www.benzinga.com/markets/cannabis/22/03/25987493/cann-american-cancels-over-3-million-common-shares
Last Prisoner Project Calls For Support Of Rudi Gammo, Imprisoned For Operating A Medical Cannabis Dispensary
September 1, 2021  |  benzinga.comhttps://www.benzinga.com/markets/cannabis/21/08/22722393/last-prisoner-project-calls-for-support-of-rudi-gammo-imprisoned-for-operating-a-medical-cannabi
Hollister Biosciences Stock Down Slightly On $17.6M Q2 2021 Revenue Report, $3.2M Of Adjusted EBITDA
August 27, 2021  |  benzinga.comhttps://www.benzinga.com/markets/cannabis/21/08/22678038/hollister-biosciences-stock-down-slightly-on-17-6m-q2-2021-revenue-report-3-2m-of-adjusted-ebitd

Top Headlines

View All Headlines
A glass Pepsi bottle and a bowl of Frito-Lay chips on a table in front of the PepsiCo corporate logo.
PepsiCo Stock Reversal Points Toward New All-Time Highs
By Thomas Hughes | April 16, 2026
A close-up of a brushed metal server panel faceplate with a dimensional Supermicro logo emblem.
95% Options Surge: Smart Money Bets Big on a Super Micro Bounce
By Jeffrey Neal Johnson | April 15, 2026
A depiction of a vast, modern corporate lobby with a polished, reflective floor, with a black wall featuring the text "JPMorgan Chase."
JPMorgan Stock Is Coiling Near All-Time Highs — Here's What Comes Next
By Thomas Hughes | April 14, 2026
A Lockheed Martin F-35 fighter jet sits inside a hangar at dusk, bearing the company logo.
Why Lockheed Martin's Earnings Miss Could Be a Blessing in Disguise
By Sam Quirke | May 4, 2026
Exterior of an Apple retail store featuring the company logo on a glass facade.
Apple’s Earnings Make $300 Look Like a Matter of When, Not If
By Sam Quirke | May 1, 2026

Abattis Bioceuticals CNSX:ATT

Abattis Bioceuticals Corp. is a specialty biotechnology company. The Company aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. It operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. It offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. It is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas